TAK — Takeda Pharmaceutical Company Limited stock price, charts and financials

QT59Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (NYSE: TAK) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
18.91
-0.14-0.73%
OverviewShort InterestFilings
TAKQT59Takeda Pharmaceutical Company Limited·NYSE
18.91-0.73%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 15, 20264Statement of changes in beneficial ownership
Sep 14, 20266-KForeign issuer report
Sep 03, 20264Statement of changes in beneficial ownership
Aug 31, 20266-KForeign issuer report
Aug 21, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 06, 20266-KForeign issuer report
Jul 30, 20266-KForeign issuer report
Jul 09, 20266-KForeign issuer report
Jul 08, 20266-KForeign issuer report
#1 / 25 of 397
Page
▼
/ 16